speb/financial-data huggingface dataset:
AAL balance_sheet (annual, 2025-12-31) — Other Properties: 7091000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Properties: 7091000000.00
AAL balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 4882000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4882000000.00
AAL income_statement (annual, 2025-12-31) — Other Special Charges: 115000000.00
AAL income_statement (quarterly, 2025-12-31) — Other Special Charges: -2000000.00
AAL balance_sheet (annual, 2025-12-31) — Payables: 2840000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Payables: 2840000000.00
AAL balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 7884000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 7884000000.00
AAL cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -31000000.00
AAL income_statement (annual, 2025-12-31) — Pretax Income: 190000000.00
AAL income_statement (quarterly, 2025-12-31) — Pretax Income: 142000000.00
AAL cash_flow (annual, 2025-12-31) — Purchase Of Investment: -4905000000.00
AAL cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -104000000.00
AAL balance_sheet (annual, 2025-12-31) — Receivables: 2075000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Receivables: 2075000000.00
AAL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 44162000000.00
AAL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11196000000.00
AAL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 2219000000.00
AAL income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 4705000000.00
AAL income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 1161000000.00
AAL cash_flow (annual, 2025-12-31) — Repayment Of Debt: -5504000000.00
AAL cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -416000000.00
AAL balance_sheet (annual, 2025-12-31) — Restricted Cash: 735000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 735000000.00
AAL income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 44000000.00
AAL income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 36000000.00
AAL balance_sheet (annual, 2025-12-31) — Retained Earnings: -6732000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -6732000000.00
AAL cash_flow (annual, 2025-12-31) — Sale Of Investment: 6189000000.00
AAL cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1248000000.00
AAL cash_flow (annual, 2025-12-31) — Sale Of PPE: 344000000.00
AAL cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 100000000.00
AAL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 1997000000.00
AAL income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 530000000.00
AAL income_statement (annual, 2025-12-31) — Selling General And Administration: 1997000000.00
AAL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 530000000.00
AAL balance_sheet (annual, 2025-12-31) — Share Issued: 660301080.00
AAL balance_sheet (quarterly, 2025-12-31) — Share Issued: 660301080.00
AAL cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 840000000.00
AAL income_statement (annual, 2025-12-31) — Special Income Charges: -159000000.00
AAL income_statement (quarterly, 2025-12-31) — Special Income Charges: -34000000.00
AAL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 57000000.00
AAL balance_sheet (annual, 2025-12-31) — Stockholders Equity: -3727000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -3727000000.00
AAL balance_sheet (annual, 2025-12-31) — Tangible Book Value: -9884000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -9884000000.00
AAL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -33390000.00
AAL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -10295774.65
AAL income_statement (annual, 2025-12-31) — Tax Provision: 79000000.00
AAL income_statement (quarterly, 2025-12-31) — Tax Provision: 43000000.00
AAL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
AAL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
AAL balance_sheet (annual, 2025-12-31) — Total Assets: 61774000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Assets: 61774000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Capitalization: 20912000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 20912000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Debt: 36884000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Debt: 36884000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -3727000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -3727000000.00
AAL income_statement (annual, 2025-12-31) — Total Expenses: 53007000000.00
AAL income_statement (quarterly, 2025-12-31) — Total Expenses: 13513000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 65501000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 65501000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 49569000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 49569000000.00
AAL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 41009000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 41009000000.00
AAL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 1467000000.00
AAL income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 452000000.00
AAL income_statement (annual, 2025-12-31) — Total Unusual Items: -159000000.00
AAL income_statement (quarterly, 2025-12-31) — Total Unusual Items: -34000000.00
AAL income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -159000000.00
AAL income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -34000000.00
AAL balance_sheet (annual, 2025-12-31) — Working Capital: -12287000000.00
AAL balance_sheet (quarterly, 2025-12-31) — Working Capital: -12287000000.00
AAL income_statement (quarterly, 2026-03-31) — +Operating Expense: 2277000000.00
AAL income_statement (quarterly, 2026-03-31) — +Total Revenue: 13912000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3610000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2008000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -25675000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7402000000.00
AAL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 661181000.00
AAL income_statement (quarterly, 2026-03-31) — Basic EPS: -0.58
AAL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1056000000.00
AAL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -811000000.00
AAL cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -811000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 6815000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 903000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 7294000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Cash Financial: 903000000.00
AAL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1949000000.00
AAL cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2328000000.00
AAL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -54000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -4077000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 592000000.00
AAL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11662000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4947000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Assets: 13984000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1053000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Debt: 4555000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5608000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 14241000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 14241000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 28406000000.00
AAL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 661181000.00
AAL income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.58
AAL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — EBIT: -79000000.00
AAL income_statement (quarterly, 2026-03-31) — EBITDA: -79000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 1219000000.00
AAL cash_flow (quarterly, 2026-03-31) — End Cash Position: 1002000000.00
AAL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1949000000.00
AAL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3412000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -4372000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 6155000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 65443000000.00
AAL income_statement (quarterly, 2026-03-31) — Gross Profit: 2250000000.00
AAL income_statement (quarterly, 2026-03-31) — Interest Expense: 397000000.00
AAL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 397000000.00
AAL income_statement (quarterly, 2026-03-31) — Interest Income: 55000000.00
AAL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 55000000.00
AAL cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 454000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Inventory: 3131000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 24000000000.00
AAL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2328000000.00
AAL cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 997000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 10605000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 360000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 5762000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 23522000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 29284000000.00
AAL cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 997000000.00
AAL cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2324000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Net Debt: 27174000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -382000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Interest Income: -342000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -1510000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1881000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1327000000.00
AAL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -342000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -68000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -7000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Net PPE: 39768000000.00
AAL cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -554000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -10232000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2457000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 7376000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 7376000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 2457000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1219000000.00
AAL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -65000000.00
AAL income_statement (quarterly, 2026-03-31) — Normalized Income: -370764705.88
AAL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 4223000000.00
AAL income_statement (quarterly, 2026-03-31) — Operating Income: -27000000.00
AAL income_statement (quarterly, 2026-03-31) — Operating Revenue: 12709000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 661385137.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 834000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 4195000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -4372000000.00
AAL income_statement (quarterly, 2026-03-31) — Other Income Expense: -107000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2064000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1374000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1530000000.00
AAL income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -93000000.00
AAL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1770000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Properties: 6943000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 6391000000.00
AAL income_statement (quarterly, 2026-03-31) — Other Special Charges: 14000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Payables: 3610000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 8557000000.00
AAL income_statement (quarterly, 2026-03-31) — Pretax Income: -476000000.00
AAL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -2773000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Receivables: 2008000000.00
AAL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11662000000.00
AAL income_statement (quarterly, 2026-03-31) — Rent Expense Supplemental: 1201000000.00
AAL cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2878000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 717000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -7114000000.00
AAL cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 1263000000.00
AAL income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 507000000.00
AAL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 507000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Share Issued: 661385137.00
AAL cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -554000000.00
AAL income_statement (quarterly, 2026-03-31) — Special Income Charges: -14000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -4077000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -10232000000.00
AAL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2764705.88
AAL income_statement (quarterly, 2026-03-31) — Tax Provision: -94000000.00
AAL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
AAL balance_sheet (quarterly, 2026-03-31) — Total Assets: 63738000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 19445000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Debt: 34892000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -4077000000.00
AAL income_statement (quarterly, 2026-03-31) — Total Expenses: 13939000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 67815000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 49754000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 39409000000.00
AAL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -41000000.00
AAL income_statement (quarterly, 2026-03-31) — Total Unusual Items: -14000000.00
AAL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -14000000.00
AAL balance_sheet (quarterly, 2026-03-31) — Working Capital: -14422000000.00
AAL income_statement (quarterly, 2026-06-30) — +Operating Expense: 2538000000.00
AAL income_statement (quarterly, 2026-06-30) — +Total Revenue: 16735000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 3637000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 1893000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Accumulated Depreciation: -26098000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 7421000000.00
AAL income_statement (quarterly, 2026-06-30) — Basic Average Shares: 662190000.00
AAL income_statement (quarterly, 2026-06-30) — Basic EPS: 0.11
AAL cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 1002000000.00
AAL cash_flow (quarterly, 2026-06-30) — Capital Expenditure: -822000000.00
AAL cash_flow (quarterly, 2026-06-30) — Capital Expenditure Reported: -822000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Capital Lease Obligations: 6802000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Capital Stock: 7000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 1028000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 7770000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Cash Financial: 1028000000.00
AAL cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Financing Activities: 784000000.00
AAL cash_flow (quarterly, 2026-06-30) — Cash Flow From Continuing Investing Activities: -1111000000.00
AAL cash_flow (quarterly, 2026-06-30) — Changes In Cash: 144000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Common Stock: 7000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Common Stock Equity: -3972000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Construction In Progress: 571000000.00
AAL income_statement (quarterly, 2026-06-30) — Cost Of Revenue: 13744000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Accrued Expenses: 5069000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Assets: 14276000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Capital Lease Obligation: 1052000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Debt: 3094000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Debt And Capital Lease Obligation: 4146000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Deferred Liabilities: 13904000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Deferred Revenue: 13904000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Current Liabilities: 26756000000.00
AAL income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 662613000.00
AAL income_statement (quarterly, 2026-06-30) — Diluted EPS: 0.11
AAL income_statement (quarterly, 2026-06-30) — Diluted NI Availto Com Stockholders: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — EBIT: 516000000.00
AAL income_statement (quarterly, 2026-06-30) — EBITDA: 516000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Employee Benefits: 1160000000.00
AAL cash_flow (quarterly, 2026-06-30) — End Cash Position: 1146000000.00
AAL cash_flow (quarterly, 2026-06-30) — Financing Cash Flow: 784000000.00
AAL cash_flow (quarterly, 2026-06-30) — Free Cash Flow: -351000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Gains Losses Not Affecting Retained Earnings: -4357000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Goodwill: 4091000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Goodwill And Other Intangible Assets: 6160000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Gross PPE: 66099000000.00
AAL income_statement (quarterly, 2026-06-30) — Gross Profit: 2991000000.00
AAL income_statement (quarterly, 2026-06-30) — Interest Expense: 409000000.00
AAL income_statement (quarterly, 2026-06-30) — Interest Expense Non Operating: 409000000.00
AAL income_statement (quarterly, 2026-06-30) — Interest Income: 74000000.00
AAL income_statement (quarterly, 2026-06-30) — Interest Income Non Operating: 74000000.00
AAL cash_flow (quarterly, 2026-06-30) — Interest Paid Supplemental Data: 309000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Inventory: 3107000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Invested Capital: 24955000000.00
AAL cash_flow (quarterly, 2026-06-30) — Investing Cash Flow: -1111000000.00
AAL cash_flow (quarterly, 2026-06-30) — Issuance Of Debt: 3521000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Land And Improvements: 10701000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Line Of Credit: 0.00
AAL balance_sheet (quarterly, 2026-06-30) — Long Term Capital Lease Obligation: 5750000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Long Term Debt: 25833000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Long Term Debt And Capital Lease Obligation: 31583000000.00
AAL cash_flow (quarterly, 2026-06-30) — Long Term Debt Issuance: 3521000000.00
AAL cash_flow (quarterly, 2026-06-30) — Long Term Debt Payments: -2327000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Net Debt: 27899000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income Common Stockholders: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income Continuous Operations: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income From Continuing And Discontinued Operation: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income From Continuing Operation Net Minority Interest: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Income Including Noncontrolling Interests: 71000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Interest Income: -335000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Investment Purchase And Sale: -347000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Issuance Payments Of Debt: 834000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Long Term Debt Issuance: 1194000000.00
AAL income_statement (quarterly, 2026-06-30) — Net Non Operating Interest Income Expense: -335000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Other Financing Charges: -50000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Other Investing Changes: -2000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Net PPE: 40001000000.00
AAL cash_flow (quarterly, 2026-06-30) — Net Short Term Debt Issuance: -360000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Net Tangible Assets: -10132000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Assets: 2417000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Liabilities: 7220000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Revenue: 7220000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Non Current Deferred Taxes Assets: 2417000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 1160000000.00
AAL income_statement (quarterly, 2026-06-30) — Normalized EBITDA: 523000000.00
AAL income_statement (quarterly, 2026-06-30) — Normalized Income: 75644859.81
AAL cash_flow (quarterly, 2026-06-30) — Operating Cash Flow: 471000000.00
AAL income_statement (quarterly, 2026-06-30) — Operating Income: 453000000.00
AAL income_statement (quarterly, 2026-06-30) — Operating Revenue: 15487000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Ordinary Shares Number: 661936666.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Current Assets: 797000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Current Borrowings: 3094000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Equity Adjustments: -4357000000.00
AAL income_statement (quarterly, 2026-06-30) — Other Income Expense: -11000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Intangible Assets: 2069000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Non Current Assets: 1379000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Non Current Liabilities: 1486000000.00
AAL income_statement (quarterly, 2026-06-30) — Other Non Operating Income Expenses: -4000000.00
AAL income_statement (quarterly, 2026-06-30) — Other Operating Expenses: 1935000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Properties: 6919000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Other Short Term Investments: 6742000000.00
AAL income_statement (quarterly, 2026-06-30) — Other Special Charges: 7000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Payables: 3637000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Payables And Accrued Expenses: 8706000000.00
AAL income_statement (quarterly, 2026-06-30) — Pretax Income: 107000000.00
AAL cash_flow (quarterly, 2026-06-30) — Purchase Of Investment: -924000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Receivables: 1893000000.00
AAL income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 13744000000.00
AAL income_statement (quarterly, 2026-06-30) — Rent Expense Supplemental: 1286000000.00
AAL cash_flow (quarterly, 2026-06-30) — Repayment Of Debt: -2687000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Restricted Cash: 709000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Retained Earnings: -7043000000.00
AAL cash_flow (quarterly, 2026-06-30) — Sale Of Investment: 577000000.00
AAL income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 603000000.00
AAL income_statement (quarterly, 2026-06-30) — Selling General And Administration: 603000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Share Issued: 661936666.00
AAL cash_flow (quarterly, 2026-06-30) — Short Term Debt Payments: -360000000.00
AAL income_statement (quarterly, 2026-06-30) — Special Income Charges: -7000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: -3972000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: -10132000000.00
AAL income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: -2355140.19
AAL income_statement (quarterly, 2026-06-30) — Tax Provision: 36000000.00
AAL income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.34
AAL balance_sheet (quarterly, 2026-06-30) — Total Assets: 64233000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 21861000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Debt: 35729000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: -3972000000.00
AAL income_statement (quarterly, 2026-06-30) — Total Expenses: 16282000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 68205000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Non Current Assets: 49957000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Total Non Current Liabilities Net Minority Interest: 41449000000.00
AAL income_statement (quarterly, 2026-06-30) — Total Operating Income As Reported: 446000000.00
AAL income_statement (quarterly, 2026-06-30) — Total Unusual Items: -7000000.00
AAL income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: -7000000.00
AAL balance_sheet (quarterly, 2026-06-30) — Working Capital: -12480000000.00
AAL.AX income_statement (annual, 2022-06-30) — +Operating Expense: 11500000.00
AAL.AX income_statement (annual, 2022-06-30) — +Total Revenue: 75500000.00
AAL.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 286588003.00
AAL.AX income_statement (annual, 2022-06-30) — Basic EPS: 0.01
AAL.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -13900000.00
AAL.AX cash_flow (annual, 2022-06-30) — Cash Dividends Paid: -400000.00
AAL.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 4600000.00
AAL.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -11900000.00
AAL.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: 10500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 3200000.00
AAL.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -74300000.00
AAL.AX cash_flow (annual, 2022-06-30) — Classesof Cash Receiptsfrom Operating Activities: 85200000.00
AAL.AX cash_flow (annual, 2022-06-30) — Common Stock Dividend Paid: -400000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 0.00
AAL.AX income_statement (annual, 2022-06-30) — Cost Of Revenue: 61300000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Current Assets: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 0.00
AAL.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 4600000.00
AAL.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 4600000.00
AAL.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 4600000.00
AAL.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 286588003.00
AAL.AX income_statement (annual, 2022-06-30) — Diluted EPS: 0.01
AAL.AX income_statement (annual, 2022-06-30) — EBIT: 5000000.00
AAL.AX income_statement (annual, 2022-06-30) — EBITDA: 9600000.00
AAL.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3700000.00
AAL.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 4600000.00
AAL.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -3400000.00
AAL.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 6800000.00
AAL.AX income_statement (annual, 2022-06-30) — Gross Profit: 14200000.00
AAL.AX cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: -100000.00
AAL.AX income_statement (annual, 2022-06-30) — Interest Expense: 500000.00
AAL.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Interest Paid Direct: -700000.00
AAL.AX cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 700000.00
AAL.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 200000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 0.00
AAL.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -11900000.00
AAL.AX cash_flow (annual, 2022-06-30) — Issuance Of Debt: 2000000.00
AAL.AX cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 2000000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Interest Income: -500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: 2000000.00
AAL.AX cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: 2000000.00
AAL.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: 3000000.00
AAL.AX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: 1700000.00
AAL.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -13600000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 0.00
AAL.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: 9600000.00
AAL.AX income_statement (annual, 2022-06-30) — Normalized Income: 3200000.00
AAL.AX income_statement (annual, 2022-06-30) — Operating Income: 2700000.00
AAL.AX income_statement (annual, 2022-06-30) — Operating Revenue: 75500000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 286588003.00
AAL.AX income_statement (annual, 2022-06-30) — Other Gand A: 6800000.00
AAL.AX income_statement (annual, 2022-06-30) — Other Income Expense: 2300000.00
AAL.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 2300000.00
AAL.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 100000.00
AAL.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -74300000.00
AAL.AX income_statement (annual, 2022-06-30) — Pretax Income: 4500000.00
AAL.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -13900000.00
AAL.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Customers: 83600000.00
AAL.AX cash_flow (annual, 2022-06-30) — Receiptsfrom Government Grants: 1600000.00
AAL.AX income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 61300000.00
AAL.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 4600000.00
AAL.AX cash_flow (annual, 2022-06-30) — Sale Of PPE: 300000.00
AAL.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 6800000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Share Issued: 286588003.00
AAL.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 0.00
AAL.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
AAL.AX income_statement (annual, 2022-06-30) — Tax Provision: 1300000.00
AAL.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.29
AAL.AX cash_flow (annual, 2022-06-30) — Taxes Refund Paid Direct: 100000.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Assets: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2022-06-30) — Working Capital: 0.00
AAL.AX income_statement (annual, 2023-06-30) — +Operating Expense: 17000000.00
AAL.AX income_statement (annual, 2023-06-30) — +Total Revenue: 84400000.00
AAL.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 286588003.00
AAL.AX income_statement (annual, 2023-06-30) — Basic EPS: 0.02
AAL.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3700000.00
AAL.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -11400000.00
AAL.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -2900000.00
AAL.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -11200000.00
AAL.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: 13400000.00
AAL.AX cash_flow (annual, 2023-06-30) — Changes In Cash: -700000.00
AAL.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -79800000.00
AAL.AX cash_flow (annual, 2023-06-30) — Classesof Cash Receiptsfrom Operating Activities: 94100000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 0.00
AAL.AX income_statement (annual, 2023-06-30) — Cost Of Revenue: 59900000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Current Assets: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 0.00
AAL.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 6500000.00
AAL.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 6500000.00
AAL.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 6500000.00
AAL.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 286588003.00
AAL.AX income_statement (annual, 2023-06-30) — Diluted EPS: 0.02
AAL.AX income_statement (annual, 2023-06-30) — EBIT: 8000000.00
AAL.AX income_statement (annual, 2023-06-30) — EBITDA: 14500000.00
AAL.AX cash_flow (annual, 2023-06-30) — End Cash Position: 3000000.00
AAL.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: -2900000.00
AAL.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: 2000000.00
AAL.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 10700000.00
AAL.AX income_statement (annual, 2023-06-30) — Gross Profit: 24500000.00
AAL.AX income_statement (annual, 2023-06-30) — Interest Expense: 900000.00
AAL.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 900000.00
AAL.AX cash_flow (annual, 2023-06-30) — Interest Paid Direct: -1100000.00
AAL.AX cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 1100000.00
AAL.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 200000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 0.00
AAL.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -11200000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Interest Income: -900000.00
AAL.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -900000.00
AAL.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -2900000.00
AAL.AX cash_flow (annual, 2023-06-30) — Net Other Investing Changes: 200000.00
AAL.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -11400000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 0.00
AAL.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: 14500000.00
AAL.AX income_statement (annual, 2023-06-30) — Normalized Income: 4900000.00
AAL.AX income_statement (annual, 2023-06-30) — Operating Income: 7500000.00
AAL.AX income_statement (annual, 2023-06-30) — Operating Revenue: 84400000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 286588003.00
AAL.AX income_statement (annual, 2023-06-30) — Other Gand A: 10700000.00
AAL.AX income_statement (annual, 2023-06-30) — Other Income Expense: 500000.00
AAL.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 500000.00
AAL.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: -200000.00
AAL.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -79800000.00
AAL.AX income_statement (annual, 2023-06-30) — Pretax Income: 7100000.00
AAL.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -11400000.00
AAL.AX cash_flow (annual, 2023-06-30) — Receiptsfrom Customers: 94100000.00
AAL.AX income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 59900000.00
AAL.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 6500000.00
AAL.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 10700000.00
AAL.AX balance_sheet (annual, 2023-06-30) — Share Issued: 286588003.00
AAL.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 0.00
AAL.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
AAL.AX income_statement (annual, 2023-06-30) — Tax Provision: 2200000.00
AAL.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.31
AAL.AX balance_sheet (annual, 2023-06-30) — Total Assets: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
AAL.AX balance_sheet (annual, 2023-06-30) — Working Capital: 0.00
AAL.AX income_statement (annual, 2024-06-30) — +Operating Expense: 50769407.00
AAL.AX income_statement (annual, 2024-06-30) — +Total Revenue: 96267729.00
AAL.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 10336501.00
AAL.AX balance_sheet (annual, 2024-06-30) — Accounts Receivable: 13371884.00
AAL.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -31778276.00
AAL.AX income_statement (annual, 2024-06-30) — Amortization: 150.00
AAL.AX income_statement (annual, 2024-06-30) — Amortization Of Intangibles Income Statement: 150.00
AAL.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 165553232.00
AAL.AX income_statement (annual, 2024-06-30) — Basic EPS: 0.02
AAL.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 2951515.00
AAL.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -19469754.00
AAL.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 6161077.00
AAL.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 54622759.00
AAL.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 23595792.00
AAL.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 23595792.00
AAL.AX cash_flow (annual, 2024-06-30) — Cash Dividends Paid: -5000000.00
AAL.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 23595792.00
AAL.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 23121343.00
AAL.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -19814536.00
AAL.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: 17337470.00
AAL.AX cash_flow (annual, 2024-06-30) — Changes In Cash: 20644277.00
AAL.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -84991905.00
AAL.AX cash_flow (annual, 2024-06-30) — Classesof Cash Receiptsfrom Operating Activities: 106023911.00
AAL.AX balance_sheet (annual, 2024-06-30) — Common Stock: 54622759.00
AAL.AX cash_flow (annual, 2024-06-30) — Common Stock Dividend Paid: -5000000.00
AAL.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 56744040.00
AAL.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 30000000.00
AAL.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -2809885.00
AAL.AX balance_sheet (annual, 2024-06-30) — Construction In Progress: 15189509.00
AAL.AX income_statement (annual, 2024-06-30) — Cost Of Revenue: 35450856.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Assets: 43807630.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 756879.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Debt: 16583291.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 17340170.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 7519051.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 2884488.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Deferred Taxes Liabilities: 4634563.00
AAL.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 42021316.00
AAL.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 7736679.00
AAL.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 7736679.00
AAL.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 7736529.00
AAL.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 165553232.00
AAL.AX income_statement (annual, 2024-06-30) — Diluted EPS: 0.02
AAL.AX income_statement (annual, 2024-06-30) — EBIT: 10518751.00
AAL.AX income_statement (annual, 2024-06-30) — EBITDA: 18255430.00
AAL.AX balance_sheet (annual, 2024-06-30) — Employee Benefits: 297092.00
AAL.AX cash_flow (annual, 2024-06-30) — End Cash Position: 23595792.00
AAL.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 23121343.00
AAL.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -2132284.00
AAL.AX income_statement (annual, 2024-06-30) — Gain On Sale Of Ppe: 129738.00
AAL.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: -13517763.00
AAL.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 33701802.00
AAL.AX balance_sheet (annual, 2024-06-30) — Goodwill: 239784.00
AAL.AX balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 239934.00
AAL.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 99590028.00
AAL.AX income_statement (annual, 2024-06-30) — Gross Profit: 60816873.00
AAL.AX cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 2521998.00
AAL.AX income_statement (annual, 2024-06-30) — Interest Expense: 881005.00
AAL.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 881005.00
AAL.AX income_statement (annual, 2024-06-30) — Interest Income: 165801.00
AAL.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 165801.00
AAL.AX cash_flow (annual, 2024-06-30) — Interest Paid Direct: -1338339.00
AAL.AX cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 1338339.00
AAL.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 165801.00
AAL.AX balance_sheet (annual, 2024-06-30) — Inventory: 5893274.00
AAL.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 76119686.00
AAL.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -19814536.00
AAL.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 30000000.00
AAL.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 9358981.00
AAL.AX balance_sheet (annual, 2024-06-30) — Land And Improvements: 22245664.00
AAL.AX balance_sheet (annual, 2024-06-30) — Leases: 891939.00
AAL.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 5404198.00
AAL.AX balance_sheet (annual, 2024-06-30) — Long Term Debt: 2792355.00
AAL.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 8196553.00
AAL.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 9358981.00
AAL.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -2175000.00
AAL.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 53886860.00
AAL.AX income_statement (annual, 2024-06-30) — Minority Interests: -110861.00
AAL.AX cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: -765000.00
AAL.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 27190115.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income: 3553543.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 3553543.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 3664404.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 3553543.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 3553543.00
AAL.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 3664404.00
AAL.AX income_statement (annual, 2024-06-30) — Net Interest Income: -1172538.00
AAL.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 7183981.00
AAL.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 7183981.00
AAL.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -1172538.00